Corporate Tech Investors

Biosynex

Biosynex is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and is specialized in the design and distribution of rapid diagnostic tests (RDT). Today, BIOSYNEX is the leader of the RDT French market. Fast and easy to use, these RDTs are commercialized in France and in some 60 countries through local distributors. By targeting the general public and health professionals, BIOSYNEX brings concrete and effective answers to public health issues at the heart of today's preoccupations.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/22/2020

Transaction History

Our records indicate that Biosynex invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Thierry Paper

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Biosynex has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

BioMotiv | BioTex

Share this article

About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary